In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Editorial Advisory Board
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Guidelines for Contributors
Report Store
UsernamePublicRestriction

Sorin Biomedica Cardio SPA

Division of Cyberonics Inc./Sorin Group SPA

Latest From Sorin Biomedica Cardio SPA

Bookmark

Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models

Healthy market growth, the biggest ever M&A deal, a record number of billion-dollar takeovers, and the IPO market in impressive bounce-back…2014 was a year of superlatives for the global medtech industry. But with more expected of manufacturers while health care spending remains in the doldrums and demand for care rises, the long-term medtech winners will be those who can forecast how and where to make an impact on both costs and patient outcomes.

Medical Device Deals
Bookmark

Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models

Medtech manufacturers saw 2014 as the year of the medtech mega-merger and a rebound in IPOs. But the market is changing, and companies are increasingly cast as service providers who must deliver value.

Medical Device Deals
Bookmark

Invatec: From Garage to Global Cardiology Brand

Staying close to the customer has become a cliche--one that most companies begin by adhering to, but which becomes more difficult to maintain as a company grows. Invatec started as a family-run business centered around turning physicians' ideas into new products. The success of Invatec's initial products led to the company's transformation into one selling both cardiology devices and innovative products in the carotid and peripheral markets. Invatec started by building a growing global business outside of the US, and it is seeing early success from its initial US product introductions, where it is challenging the major cardiology companies on their home turf.
Medical Device Strategy
Bookmark

At PCR, How Big is Small?

With each passing year, clinical trials reaffirm the efficacy of drug-eluting stents in reducing or eliminating restenosis. But the devices' success have raised concerns of a different sort: safety, and specifically, the risk of subacute and late stent thrombosis.
Medical Device Clinical Trials
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Alias(es)
  • Sorin Biomedica SPA
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • Cyberonics Inc.
  • Senior Management
  • Contact Info
  • Sorin Biomedica Cardio SPA
    P.O. Box E Salugia VC, 13040
    Italy
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By